The R21/Matrix-M malaria vaccine: questions remain
Peter Aaby1, Anders Björkman2, Allan Schapira3
1Bandim Health Project, Indepth Network, Bissau 1004, Guinea-Bissau.
Lancet (London, England)
|January 25, 2025
Abstract
No abstract available in PubMed .
More Related Videos
09:13Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
17.3K
08:46Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
Published on: May 18, 2016
17.2K
